S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Deep Track Capital/Q2 2022

Deep Track Capital

Periodo: Q2 2022 Β· Depositato: 2022-08-12
Vedi su SEC EDGAR β†—
AUM
$1.52B
Valore totale del portafoglio
Posizioni
51
Titoli dichiarati
Prima Posizione
GBT
7.7% $116.5M
Var. Trimestrali
+6 / -7
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2022-08-12) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
GBTGLOBAL BLOOD THERAPEUTICS IN$116.5M7.66%β€”β€”
7.7%
NVCRNOVOCURE LTD$93.2M6.13%$69.50$17.20-75.3%
6.1%
TVTXTRAVERE THERAPEUTICS INC$86.8M5.70%$24.23$56.92+134.9%
5.7%
JAZZJAZZ PHARMACEUTICALS PLC$78.0M5.13%$156.01$243.47+56.1%
5.1%
ALNYCALLALNYLAM PHARMACEUTICALS INC$72.9M4.79%$145.85$312.78+114.5%
4.8%
KURAKURA ONCOLOGY INC$67.8M4.46%$18.33$11.10-39.4%
4.5%
MDGLMADRIGAL PHARMACEUTICALS INC$64.8M4.26%$71.58$528.10+637.8%
4.3%
KDNYCHINOOK THERAPEUTICS INC$60.0M3.94%β€”β€”
3.9%
BMRNBIOMARIN PHARMACEUTICAL INC$54.2M3.56%$82.87$58.99-28.8%
3.6%
FATEFATE THERAPEUTICS INC$50.0M3.29%$24.78$2.92-88.2%
3.3%
BCYCBICYCLE THERAPEUTICS PLC$48.7M3.20%$16.78$4.35-74.1%
3.2%
BEAMBEAM THERAPEUTICS INC$48.4M3.18%$38.71$34.79-10.1%
3.2%
ISEEIVERIC BIO INC$43.3M2.85%β€”β€”
2.9%
AGENAGENUS INC$43.1M2.84%$38.08$3.49-90.8%
2.8%
ESPRESPERION THERAPEUTICS INC NE$38.2M2.51%$6.36$3.16-50.3%
2.5%
RPTXREPARE THERAPEUTICS INC$37.9M2.49%β€”β€”
2.5%
NUVBNUVATION BIO INC$37.2M2.44%$3.24$5.70+75.9%
2.4%
IMVTIMMUNOVANT INC$36.9M2.42%$3.90$38.79+894.6%
2.4%
NKTXNKARTA INC$34.7M2.28%$12.32$3.22-73.9%
2.3%
NRIXNURIX THERAPEUTICS INC$30.9M2.03%$12.67$23.97+89.2%
2.0%
FMTXFORMA THERAPEUTICS HLDGS INC$27.9M1.83%β€”β€”
1.8%
TCDAQTRICIDA INC$26.4M1.74%β€”β€”
1.7%
ACADACADIA PHARMACEUTICALS INC$24.4M1.61%$14.09$25.97+84.3%
1.6%
DYNDYNE THERAPEUTICS INC$24.0M1.58%$6.87$23.07+235.8%
1.6%
FDMT4D MOLECULAR THERAPEUTICS IN$21.9M1.44%$6.98$13.00+86.3%
1.4%
KROSKEROS THERAPEUTICS INC$20.4M1.34%$27.63$11.26-59.3%
1.3%
CRNXCRINETICS PHARMACEUTICALS IN$19.6M1.29%$18.65$42.23+126.4%
1.3%
KALVKALVISTA PHARMACEUTICALS INC$17.9M1.18%$9.84β€”
1.2%
DICEDICE THERAPEUTICS INC$16.2M1.06%β€”β€”
1.1%
INZYINOZYME PHARMA INC$15.5M1.02%β€”β€”
1.0%

AttivitΓ  Trimestre su Trimestre

Q2 2022 vs. Q1 2022

Nuove Posizioni (6)

TickerEmittenteNozionaleDal Deposito
BMRNBIOMARIN PHARMACEUTICAL INC$54.2M-28.8%
NRIXNURIX THERAPEUTICS INC$30.9M+89.2%
ACADACADIA PHARMACEUTICALS INC$24.4M+84.3%
INZYINOZYME PHARMA INC$15.5M
SDGRSCHRODINGER INC$14.8M
ACETADICET BIO INC$13.0M

Posizioni Chiuse (7)

TickerEmittenteNozionale
ENTAENANTA PHARMACEUTICALS INC$14.2M
RXDXPROMETHEUS BIOSCIENCES INC$9.3M
NKTRNEKTAR THERAPEUTICS$5.4M
NKTRNEKTAR THERAPEUTICS$2.7M
VERVVERVE THERAPEUTICS INC$2.3M
AUTLAUTOLUS THERAPEUTICS PLC$1.6M
RFLRAFAEL HLDGS INC$0.3M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
NUVBNUVATION BIO INC$31.1M+892.8%+75.9%
RLMDRELMADA THERAPEUTICS INC$6.7M+389.6%
FMTXFORMA THERAPEUTICS HLDGS INC$12.5M+144.0%
PTGXPUTPROTAGONIST THERAPEUTICS INC$-1.4M+75.7%
BEAMBEAM THERAPEUTICS INC$4.6M+63.7%-10.1%
AGENAGENUS INC$8.7M+58.9%-90.8%
GBTGLOBAL BLOOD THERAPEUTICS IN$36.7M+58.2%
BCYCBICYCLE THERAPEUTICS PLC$-32.8M+56.3%-74.1%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
SAGESAGE THERAPEUTICS INC$-16.8M-74.5%
ATYRATYR PHARMA INC$-4.7M-71.7%
KROSKEROS THERAPEUTICS INC$-54.6M-46.4%-59.3%
GRTSQGRITSTONE BIO INC$-8.1M-42.4%
CRNXCRINETICS PHARMACEUTICALS IN$-14.2M-31.7%+126.4%
PASGPASSAGE BIO INC$-5.0M-31.3%
VIGLVIGIL NEUROSCIENCE INC$-1.9M-20.8%
DICEDICE THERAPEUTICS INC$-7.7M-16.6%
← Torna agli Hedge Fund